ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMA....MD..........*JBDM Ver 2.0.16 (1th of February 2022) - 2999001/03515490CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120220914W173deBibliographieenBibliographyfrBibliographieEP17853838.5201709202019021820210201enenen201662397752 P20160921US201762515480 P20170605US2022091420223720190731201931202208102022322022031720220914202237C07K 16/28 20060101AFI20200324BHEP A61K 39/395 20060101ALI20200324BHEP A61P 29/00 20060101ALI20200324BHEP A61P 35/00 20060101ALI20200324BHEP A61P 37/06 20060101ALI20200324BHEP C07K 16/2803 20130101 LI20190403BHEP C07K2317/24 20130101 LA20190403BHEP C07K2317/30 20130101 LA20190403BHEP C07K2317/34 20130101 LA20190403BHEP A61K2039/505 20130101 LA20180419BHEP A61K2039/507 20130101 LA20180419BHEP C07K 16/2827 20130101 LA20180419BHEP C07K2317/622 20130101 LA20180419BHEP C07K2317/76 20130101 LA20180419BHEP C07K2317/92 20130101 LA20180419BHEP C07K2317/23 20130101 LA20200120BHEP A61P 1/04 20180101 LI20200318BHEP A61P 11/00 20180101 LI20200318BHEP A61P 11/06 20180101 LI20200318BHEP A61P 13/12 20180101 LI20200319BHEP A61P 15/00 20180101 LI20200319BHEP A61P 17/00 20180101 LI20200319BHEP A61P 17/04 20180101 LI20200320BHEP A61P 17/06 20180101 LI20200320BHEP A61P 19/02 20180101 LI20200320BHEP A61P 21/00 20180101 LI20200320BHEP A61P 21/04 20180101 LI20200320BHEP A61P 25/28 20180101 LI20200324BHEP A61P 29/00 20180101 LI20200324BHEP A61P 31/04 20180101 LI20200327BHEP A61P 35/00 20180101 LI20200327BHEP A61P 3/10 20180101 LI20200330BHEP A61P 37/00 20180101 LI20200331BHEP A61P 37/06 20180101 LI20200331BHEP A61P 9/00 20180101 LI20200331BHEP A61P 9/10 20180101 LI20200331BHEP deANTIKÖRPER GEGEN SIGNALREGULATORISCHES PROTEIN ALPHA UND VERFAHREN ZUR VERWENDUNGenANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USEfrANTICORPS CONTRE LA PROTÉINE RÉGULATRICE DE SIGNAL ALPHA ET PROCÉDÉS D'UTILISATIONWO-A1-2013/056352WO-A1-2016/063233WO-A1-2016/063233WO-A2-2015/138600US-A1- 2003 054 415US-A1- 2003 054 415SEIFFERT M ET AL: "HUMAN SIGNAL-REGULATORY PROTEIN IS EXPRESSED ON NORMAL, BUT NOT ON SUBSETS OF LEUKEMIC MYELOID CELLS AND MEDIATES CELLULAR ADHESION INVOLVING ITS COUNTERRECEPTOR CD47", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 94, no. 11, 1 December 1999 (1999-12-01), pages 3633-3643, XP000973562, ISSN: 0006-4971M. SEIFFERT: "Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38- hematopoietic cells", BLOOD, vol. 97, no. 9, 1 May 2001 (2001-05-01), pages 2741-2749, XP055056672, ISSN: 0006-4971, DOI: 10.1182/blood.V97.9.2741W. Y. LEE ET AL: "Novel Structural Determinants on SIRP that Mediate Binding to CD47", THE JOURNAL OF IMMUNOLOGY, vol. 179, no. 11, 19 November 2007 (2007-11-19), pages 7741-7750, XP055497847, ISSN: 0022-1767, DOI: 10.4049/jimmunol.179.11.7741X. W. ZHAO ET AL: "CD47-signal regulatory protein-? (SIRP?) interactions form a barrier for antibody-mediated tumor cell destruction", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 108, no. 45, 8 November 2011 (2011-11-08), pages 18342-18347, XP055055636, ISSN: 0027-8424, DOI: 10.1073/pnas.1106550108JOANNE E NETTLESHIP ET AL: "Crystal structure of signal regulatory protein gamma (SIRP[gamma]) in complex with an antibody Fab frag", BMC STRUCTURAL BIOLOGY, BIOMED CENTRAL LTD., LONDON, GB, vol. 13, no. 1, 4 July 2013 (2013-07-04), page 13, XP021156553, ISSN: 1472-6807, DOI: 10.1186/1472-6807-13-13SEIFFERT, M. ET AL.: 'Human Signal-Regulatory Protein Is Expressed on Normal, But Not on Subsets of Leukemic Myeloid Cells and Mediates Cellular Adhesion Involving Its Counterreceptor CD 47' BLOOD vol. 94, no. 11, 1999, pages 3633 - 3643, XP000973562SEIFFERT, M. ET AL.: 'Signal-regulatory protein a (SIRPa) but not SIRPb is involved in T- cell activation, binds to CD 47 with high affinity, and is expressed on immature CD 34+ CD 38- hematopoietic cells' BLOOD vol. 97, no. 9, pages 2741 - 2749, XP055056672LEE, W. ET AL.: 'Novel Structural Determinants on SIRPa that Mediate Binding to CD 47' THE JOURNAL OF IMMUNOLOGY vol. 179, 2007, pages 7741 - 7750, XP055497847ZHAO, X. ET AL.: 'CD 47-signal regulatory protein-a (SIRPa) interactions form a barrier for antibody-mediated tumor cell destruction' PNAS USA vol. 108, no. 45, 2011, pages 18342 - 18347, XP055055636NETTLESHIP, J. ET AL.: 'Crystal structure of signal regulatory protein gamma (SIRPg) in complex with an antibody Fab fragment' BMC STRUCTURAL BIOLOGY vol. 13, 2013, pages 1 - 8, XP0211565532020032722179377.120220616PONS, Jaumec/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100Burlingame, CA 94010USSIM, Bang Janetc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100Burlingame, CA 94010USWAN, Hongc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100Burlingame, CA 94010USKUO, Tracy Chia-Chienc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100Burlingame, CA 94010USKAUDER, Steven Elliotc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100Burlingame, CA 94010USHARRIMAN, William Donc/o Crystal Bioscience Inc. 5980 Horton Street Suite 405Emeryville, CA 94608-2059USIZQUIERDO, Shelleyc/o Crystal Bioscience Inc. 5980 Horton Street Suite 405Emeryville, CA 94608-2059USALX Oncology Inc.101928443N415859EP323 Allerton AvenueSouth San Francisco, CA 94080USJ A Kemp LLP10166966680 Turnmill StreetLondon EC1M 5QUGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20190218ME20190218MA20190218MD20190218US201705259220170920enWO201805766920180329201813